Inmune Bio, Inc. (INMB): Long-Term Debt

Annual figures by period end, from SEC filings.

$15.00M
As of 2024-12-31
0.0%
3-year compound annual growth
2021-12-31: $15.00M2022-12-31: $15.00M2024-12-31: $15.00M$15.00M
2021-12-31 Long-Term Debt (USD) 2024-12-31
Period endedLong-Term DebtChange YoYSource filing
2024-12-31$15.00Mn/a2025-03-27, Balance as of period end
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31$15.00M0.0%2023-03-02, Balance as of period end
2021-12-31$15.00Mn/a2022-03-03, Balance as of period end